全球新冠病毒抗體檢測試劑盒市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球新冠病毒抗體檢測試劑盒市場規模預計將從2025年的89.6億美元成長至2034年的174.2億美元，2026年至2034年的複合年成長率（CAGR）為7.67%。隨著醫療衛生系統將疾病監測、免疫評估和疫情防範列為優先事項，市場持續發展。新冠病毒抗體檢測試劑盒在疫情期間已廣泛應用，並在感染和接種疫苗後監測免疫反應方面繼續發揮至關重要的作用。人們對感染疾病防治意識的提高以及對快速診斷工具日益成長的需求正在推動市場需求。醫療專業人員越來越依賴抗體檢測來支持流行病學調查和公共衛生監測計畫。

診斷平台的技術進步提高了抗體檢測試劑盒的準確性、速度和易用性。檢查室自動化程度的提高和即時檢測解決方案的整合，正在提升醫療機構的檢測效率。實驗室和政府都在加大對感染疾病監測工作的投入，從而推動了持續的需求。此外，從新冠疫情中汲取的經驗教訓也促使全球加大對診斷基礎設施和疫情應對準備工作的投入。

預計該市場將透過向更廣泛的傳染病檢查應用領域多元化發展，保持穩定成長。未來，能夠同時檢測多種病原體的多重診斷試劑盒可能會帶來新的機會。生物技術和免疫學研究的創新將進一步提高檢測的準確性和可負擔性。隨著醫療衛生系統將應對未來感染疾病疫情的準備工作放在首位，抗體檢測技術預計仍將是全球診斷策略的關鍵組成部分。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、阻礙因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長地區和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球新冠病毒抗體檢測試劑盒市場：依試劑盒類型分類

• 市場分析、洞察與預測
• 病毒量檢測試劑盒（qPCR 和 RT-PCR）
• 病毒中和試驗試劑盒
• 抗體檢測試劑盒（ELISA）
• 病毒抗原檢測檢測套組
• 其他套件

第5章 全球新冠病毒抗體檢測試劑盒市場：依耗材分類

• 市場分析、洞察與預測
• 拭子
• 管子
• 病毒牙垢培養基
• 試劑
• 其他消耗品

第6章 全球新冠病毒抗體檢測試劑盒市場：依檢體類型分類

• 市場分析、洞察與預測
• 鼻咽拭子
• 血
• 痰
• 鼻腔抽吸物

第7章 全球新冠病毒抗體檢測試劑盒市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 診所
• 公共衛生研究所
• 私人和商業檢驗機構
• 在醫生辦公室裡
• 研究機構
• 其他最終用途

第8章 全球新冠病毒抗體檢測試劑盒市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Cepheid
  • BGI Genomics
  • Abbott Laboratories
  • BioMerieux SA
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • GenMark Diagnostics
  • Mylab Discovery Solutions
  • Qiagen
  • Quidel Corporation
  • Randox Laboratories
  • SD Biosensor

The global COVID-19 antibody detection kit market size is expected to reach USD 17.42 Billion in 2034 from USD 8.96 Billion in 2025, growing at a CAGR of 7.67 during 2026-2034.This market continues to evolve as healthcare systems emphasize disease surveillance, immunity assessment, and pandemic preparedness. COVID-19 antibody detection kits gained widespread adoption during the pandemic and remain valuable for monitoring immune responses following infection or vaccination. Growing awareness regarding infectious disease management and the need for rapid diagnostic tools are supporting market demand. Healthcare providers increasingly rely on antibody testing to support epidemiological studies and public health monitoring programs.

Technological advancements in diagnostic platforms have improved the accuracy, speed, and accessibility of antibody detection kits. The growing integration of laboratory automation and point-of-care testing solutions is enhancing testing efficiency across healthcare facilities. Research institutions and governments are investing in infectious disease monitoring initiatives, contributing to continued demand. Additionally, lessons learned from the pandemic have strengthened investments in diagnostic infrastructure and preparedness measures worldwide.

The market is expected to maintain steady growth through diversification into broader infectious disease testing applications. Future opportunities are likely to emerge from multiplex diagnostic kits capable of detecting multiple pathogens simultaneously. Innovations in biotechnology and immunology research will further improve testing accuracy and affordability. As healthcare systems prioritize preparedness against future outbreaks, antibody detection technologies are expected to remain an important component of global diagnostic strategies.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Kits

• Viral Load Testing Kits (qPCR and RT-PCR)
• Virus Neutralizing Assay Kits
• Antibody Detection Kits (ELISA)
• Viral Antigen Detection Test Kits
• Other Kits

By Consumables

• Swabs
• Tubes
• Viral Transfer Media
• Reagents
• Other Consumables

By Specimen Type

• Nose & Throat Swab
• Blood
• Sputum
• Nasal Aspirate

By End Use

• Hospitals
• Clinics
• Public Health Labs
• Private and Commercial Labs
• Physicians Labs
• Research Institutes
• Other End Uses

COMPANIES PROFILED

• Cepheid, BGI Genomics, Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories, F. Hoffmann-La Roche, GenMark Diagnostics, Mylab Discovery Solutions, Qiagen, Quidel Corporation, Randox Laboratories, SD Biosensor

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COVID-19 ANTIBODY DETECTION KIT MARKET: BY KITS 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Kits
• 4.2. Viral Load Testing Kits (qPCR and RT-PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Virus Neutralizing Assay Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Antibody Detection Kits (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Viral Antigen Detection Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COVID-19 ANTIBODY DETECTION KIT MARKET: BY CONSUMABLES 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Consumables
• 5.2. Swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Tubes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Viral Transfer Media Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COVID-19 ANTIBODY DETECTION KIT MARKET: BY SPECIMEN TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Specimen Type
• 6.2. Nose & Throat Swab Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Sputum Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Nasal Aspirate Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COVID-19 ANTIBODY DETECTION KIT MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Public Health Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Private and Commercial Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Physicians Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.8. Other End Uses Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COVID-19 ANTIBODY DETECTION KIT MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Kits
  • 8.2.2 By Consumables
  • 8.2.3 By Specimen Type
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Kits
  • 8.3.2 By Consumables
  • 8.3.3 By Specimen Type
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Kits
  • 8.4.2 By Consumables
  • 8.4.3 By Specimen Type
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Kits
  • 8.5.2 By Consumables
  • 8.5.3 By Specimen Type
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Kits
  • 8.6.2 By Consumables
  • 8.6.3 By Specimen Type
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COVID-19 ANTIBODY DETECTION KIT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Cepheid
  • 10.2.2 BGI Genomics
  • 10.2.3 Abbott Laboratories
  • 10.2.4 BioMerieux SA
  • 10.2.5 Bio-Rad Laboratories
  • 10.2.6 F. Hoffmann-La Roche
  • 10.2.7 GenMark Diagnostics
  • 10.2.8 Mylab Discovery Solutions
  • 10.2.9 Qiagen
  • 10.2.10 Quidel Corporation
  • 10.2.11 Randox Laboratories
  • 10.2.12 SD Biosensor